Home › Drug Codes › J Codes › J0703 · Cefepime HCL in Dextrose
Updated July 1st, 2026

Cefepime HCL in Dextrose J Code: J0703

Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0703, effective October 1, 2026: $4.748 per HCPCS billing unit, up 6.0% from $4.479. From CMS's final file.

?
Medicare Payment Limit ?
$4.479
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
HCPCS Added Date January 1, 2023
Manufacturer B. Braun Medical Inc
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About Cefepime HCL in Dextrose

Cefepime HCL in Dextrose is a medication aligned to the HCPCS J Code: J0703 for billing, pricing, and reimbursement purposes in the United States. It is an Antibiotic drug administered via the intravenous route and manufactured by B. Braun Medical Inc.

According to CMS Drug Use Information: Cefepime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00264-3193-11 Cefepime Hydrochloride And Dextrose B. Braun Medical Inc. 48 1000 MG / 50 ML
00264-3195-11 Cefepime Hydrochloride And Dextrose B. Braun Medical Inc. 96 2000 MG / 50 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Cefepime HCL in Dextrose Pricing & Reimbursement

J0703 Private Payer Reimbursement
$4.76 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Cefepime Hydrochloride 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J0692 Generic Code (Multiple Manufacturers) Cefepime Hydrochloride Injection, cefepime hydrochloride, 500 mg
J0701 Baxter Healthcare Cefepime Hydrochloride Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
J0703 B. Braun Medical Inc Cefepime Hydrochloride Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

Cefepime HCL in Dextrose CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Cefepime HCL in Dextrose (J0703) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0703. Wastage billing guide →

Cefepime HCL in Dextrose Medically Unlikely Edits (MUE)

The most billing units of J0703 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 mg.

Practitioner Office & Hospital Outpatient
12 units / day
= 6,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

Cefepime HCL in Dextrose Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Complicated Intra-abdominal Infections Empiric Therapy for Febrile Neutropenic Patients Pneumonia Uncomplicated Skin and Skin Structure Infections Uncomplicated and Complicated Urinary Tract Infections (including pyelonephritis)
Drug Class
Cephalosporin Antibacterial [EPC]Cephalosporins [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Cefepime Hcl In Dextrose billing and coding guide?
We have not yet identified a manufacturer source of Cefepime Hcl In Dextrose billing and coding information.
Are there any available Cefepime Hcl In Dextrose patient assistance programs?
Our team did not identify a source for Cefepime Hcl In Dextrose patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Cefepime Hcl In Dextrose prescribing information?
Cefepime HCL in Dextrose prescribing information can be found at the link below: Visit Here →
Where can I find Cefepime Hcl In Dextrose side effect information?
Information regarding Cefepime HCL in Dextrose's side effects can be found at MedlinePlus Visit Here →
Does billing Cefepime HCL in Dextrose require JZ/JW wastage modifiers?
CMS does not include Cefepime HCL in Dextrose (J0703) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0703. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to Cefepime HCL in Dextrose.

J0692CEFEPIMEInjection, cefepime hydrochloride, 500 mgMultiple ManufacturersAdded January 1, 2002J0701Cefepime HCLInjection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mgBaxter HealthcareAdded January 1, 2023J2280AVELOX I.V.Injection, moxifloxacin, 100 mgMylan PharmaceuticalsAdded January 1, 2004J2281MOXIFLOXACIN HCLInjection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mgFresenius KabiAdded January 1, 2023J0122XERAVAInjection, eravacycline, 1 mgTetraphase PharmaceuticalsAdded October 1, 2019J0458EMBLAVEOInjection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)AbbvieAdded October 1, 2025J0695ZERBAXAInjection, ceftolozane 50 mg and tazobactam 25 mgMerck Sharp & Dohme CorpAdded January 1, 2016J0744CIPRO IVInjection, ciprofloxacin for intravenous infusion, 200 mgHospiraAdded January 1, 2002J1335ERTAPENEMInjection, ertapenem sodium, 500 mgMultiple ManufacturersAdded January 1, 2004J1956LEVOFLOXACINInjection, levofloxacin, 250 mgMultiple ManufacturersAdded January 1, 1999